Advanced Neuromodulation Systems, Inc. (ANS), the company sponsoring this clinical trial, is the technology leader in implantable neurostimulation therapies. ANS has nearly 20 years of experience, numerous technological firsts, multiple awards for excellence in product design and business, and more than 25,000 patients in over 25 countries with similar ANS neurostimulators for chronic pain management. ANS’ goal is to improve the lives of the millions of people around the world who suffer with disabling pain or nervous system disorders. To learn more about ANS, visit www.ans-medical.com.

In 2005, ANS became a St. Jude Medical company. St. Jude Medical is a leading manufacturer of pacemakers, implantable defibrillators, and heart valves. Over 1 million mothers, fathers, grandparents, and children worldwide have received a life-saving St. Jude Medical device. To learn more about St. Jude Medical, visit www.sjm.com.